NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors
Journal for ImmunoTherapy of Cancer · 2024-08 · 12 (8) · e008665
DOI: 10.1136/jitc-2023-008665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 16.08.2024. Verfasst von Kensuke Nakagawara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp. Hauptthemen laut MEDLINE: Mitochondria, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Science Foundation, Chemo-Sero-Therapeutic Research Institute, the Yasuda Medical Foundation.
Abstract (Originalsprache)
Background
Antitumor effect of chimeric antigen receptor (CAR)-T cells against solid tumors is limited due to various factors, such as low infiltration rate, poor expansion capacity, and exhaustion of T cells within the tumor. NR4A transcription factors have been shown to play important roles in T-cell exhaustion in mice. However, the precise contribution of each NR4a factor to human T-cell differentiation remains to be clarified.
Methods
In this study, we deleted NR4A family factors, NR4A1 , NR4A2, and NR4A3, in human CAR-T cells recognizing human epidermal growth factor receptor type 2 (HER2) by using the CRISPR/Cas9 system. We induced T-cell exhaustion in these cells in vitro through repeated co-culturing of CAR-T cells with Her2 + A549 lung adenocarcinoma cells and evaluated cell surface markers such as memory and exhaustion phenotypes, proliferative capacity, cytokine production and metabolic activity. We validated the antitumor toxicity of NR4A1/2/3 triple knockout (TKO) CAR-T cells in vivo by transferring CAR-T cells into A549 tumor-bearing immunodeficient mice.
Results
Human NR4A-TKO CAR-T cells were resistant against exhaustion induced by repeated antigen stimulation in vitro, and maintained higher tumor-killing activity both in vitro and in vivo compared with control CAR-T cells. A comparison of the effectiveness of NR4A single, double, and TKOs demonstrated that triple KO was the most effective in avoiding exhaustion. Furthermore, a strong enhancement of antitumor effects by NR4A TKO was also observed in T cells from various donors including aged persons. Mechanistically, NR4A TKO CAR-T cells showed enhanced mitochondrial oxidative phosphorylation, therefore could persist for longer periods within the tumors.
Conclusions
NR4A factors regulate CAR-T cell persistence and stemness through mitochondrial gene expression, therefore NR4A is a highly promising target for the generation of superior CAR-T cells against solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp.
- Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
- Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
- Division of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
- Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan yoshimura@keio.jp k.nakagawara@keio.jp.
ORCID-Profile: Makoto Ando, Akihiko Yoshimura
Förderung
- Takeda Science Foundation
- Chemo-Sero-Therapeutic Research Institute
- the Yasuda Medical Foundation
- the Princess Takamatsu Cancer Research Fund
- Uehara Memorial Foundation
- the Japan Agency for Medical Research and Development (AMED)-CREST
- AMED-Moonshot
- Keio Gijuku Academic Developmental Funds
Zitieren
APA
Nakagawara, K., Ando, M., Srirat, T., Mise-Omata, S., Hayakawa, T., Ito, M., Fukunaga, K., & Yoshimura, A. (2024). NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors. Journal for ImmunoTherapy of Cancer, 12(8), e008665. https://doi.org/10.1136/jitc-2023-008665
Vancouver
Nakagawara K, Ando M, Srirat T, Mise-Omata S, Hayakawa T, Ito M, et al. NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors. Journal for ImmunoTherapy of Cancer. 2024;12(8):e008665. doi:10.1136/jitc-2023-008665
BibTeX
@article{Nakagawara2024,
author = {Nakagawara, Kensuke and Ando, Makoto and Srirat, Tanakorn and Mise-Omata, Setsuko and Hayakawa, Taeko and Ito, Minako and Fukunaga, Koichi and Yoshimura, Akihiko},
title = {NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {8},
pages = {e008665},
doi = {10.1136/jitc-2023-008665}
}
EUVIMED